SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.
Aged
Aged, 80 and over
COVID-19
/ diagnosis
COVID-19 Testing
/ methods
Cross Infection
/ epidemiology
Female
France
/ epidemiology
Hand Hygiene
/ methods
Health Personnel
Hospitals, University
/ statistics & numerical data
Humans
Infection Control
/ methods
Male
Masks
/ microbiology
Middle Aged
Pandemics
Prospective Studies
Retrospective Studies
SARS-CoV-2
/ isolation & purification
COVID-19
Hand hygiene
Healthcare-associated infection
Mask
Outbreak
SARS-CoV-2
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
05 08 2021
05 08 2021
Historique:
received:
23
11
2020
accepted:
20
07
2021
entrez:
6
8
2021
pubmed:
7
8
2021
medline:
17
8
2021
Statut:
epublish
Résumé
In healthcare facilities, nosocomial transmissions of respiratory viruses are a major issue. SARS-CoV-2 is not exempt from nosocomial transmission. Our goals were to describe COVID-19 nosocomial cases during the first pandemic wave among patients in a French university hospital and compliance with hygiene measures. We conducted a prospective observational study in Grenoble Alpes University Hospital from 01/03/2020 to 11/05/2020. We included all hospitalised patients with a documented SARS-CoV-2 diagnosis. Nosocomial case was defined by a delay of 5 days between hospitalisation and first symptoms. Hygiene measures were evaluated between 11/05/2020 and 22/05/2020. Lockdown measures were effective in France on 17/03/2020 and ended on 11/05/2020. Systematic wearing of mask was mandatory for all healthcare workers (HCW) and visits were prohibited in our institution from 13/03/2021 and for the duration of the lockdown period. Among 259 patients included, 14 (5.4%) were considered as nosocomial COVID-19. Median time before symptom onset was 25 days (interquartile range: 12-42). Eleven patients (79%) had risk factors for severe COVID-19. Five died (36%) including 4 deaths attributable to COVID-19. Two clusters were identified. The first cluster had 5 cases including 3 nosocomial acquisitions and no tested HCWs were positive. The second cluster had 3 cases including 2 nosocomial cases and 4 HCWs were positive. Surgical mask wearing and hand hygiene compliance were adequate for 95% and 61% of HCWs, respectively. The number of nosocomial COVID-19 cases in our hospital was low. Compliance regarding mask wearing, hand hygiene and lockdown measures drastically reduced transmission of the virus. Monitoring of nosocomial COVID-19 cases during the first wave enabled us to determine to what extent the hygiene measures taken were effective and patients protected. Trial registration Study ethics approval was obtained retrospectively on 30 September 2020 (CECIC Rhône-Alpes-Auvergne, Clermont-Ferrand, IRB 5891).
Sections du résumé
BACKGROUND
In healthcare facilities, nosocomial transmissions of respiratory viruses are a major issue. SARS-CoV-2 is not exempt from nosocomial transmission. Our goals were to describe COVID-19 nosocomial cases during the first pandemic wave among patients in a French university hospital and compliance with hygiene measures.
METHODS
We conducted a prospective observational study in Grenoble Alpes University Hospital from 01/03/2020 to 11/05/2020. We included all hospitalised patients with a documented SARS-CoV-2 diagnosis. Nosocomial case was defined by a delay of 5 days between hospitalisation and first symptoms. Hygiene measures were evaluated between 11/05/2020 and 22/05/2020. Lockdown measures were effective in France on 17/03/2020 and ended on 11/05/2020. Systematic wearing of mask was mandatory for all healthcare workers (HCW) and visits were prohibited in our institution from 13/03/2021 and for the duration of the lockdown period.
RESULTS
Among 259 patients included, 14 (5.4%) were considered as nosocomial COVID-19. Median time before symptom onset was 25 days (interquartile range: 12-42). Eleven patients (79%) had risk factors for severe COVID-19. Five died (36%) including 4 deaths attributable to COVID-19. Two clusters were identified. The first cluster had 5 cases including 3 nosocomial acquisitions and no tested HCWs were positive. The second cluster had 3 cases including 2 nosocomial cases and 4 HCWs were positive. Surgical mask wearing and hand hygiene compliance were adequate for 95% and 61% of HCWs, respectively.
CONCLUSIONS
The number of nosocomial COVID-19 cases in our hospital was low. Compliance regarding mask wearing, hand hygiene and lockdown measures drastically reduced transmission of the virus. Monitoring of nosocomial COVID-19 cases during the first wave enabled us to determine to what extent the hygiene measures taken were effective and patients protected. Trial registration Study ethics approval was obtained retrospectively on 30 September 2020 (CECIC Rhône-Alpes-Auvergne, Clermont-Ferrand, IRB 5891).
Identifiants
pubmed: 34353356
doi: 10.1186/s13756-021-00984-x
pii: 10.1186/s13756-021-00984-x
pmc: PMC8339707
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
114Informations de copyright
© 2021. The Author(s).
Références
J Hosp Infect. 2009 Jan;71(1):1-14
pubmed: 18952319
Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1477-88
pubmed: 24798250
Clin Spine Surg. 2020 Jul;33(6):244-246
pubmed: 32482971
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
J Infect Public Health. 2020 Dec;13(12):1862-1867
pubmed: 33144023
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Lancet Infect Dis. 2007 Apr;7(4):282-8
pubmed: 17376385
Nature. 2020 Aug;584(7820):262-267
pubmed: 32512578
Lancet Infect Dis. 2018 Aug;18(8):e217-e227
pubmed: 29680581
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Lancet Infect Dis. 2020 Nov;20(11):1263-1271
pubmed: 32679081
J Patient Saf. 2021 Jun 1;17(4):323-330
pubmed: 33994534
Virusdisease. 2020 Jun;31(2):94-96
pubmed: 32656305
J Visc Surg. 2020 Jun;157(3S1):S13-S18
pubmed: 32381426
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):879-884
pubmed: 33057812
Int J Urol. 2021 Jan;28(1):62-67
pubmed: 33051893
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Hosp Infect. 2021 Jan;107:91-94
pubmed: 32950587
JAMA Netw Open. 2020 Sep 1;3(9):e2020498
pubmed: 32902653
J Hosp Infect. 2020 Nov;106(3):621-625
pubmed: 32841703
Ann Transl Med. 2020 May;8(10):629
pubmed: 32566566
Lancet. 2003 May 3;361(9368):1519-20
pubmed: 12737864
Int Orthop. 2020 Dec;44(12):2505-2513
pubmed: 32914217
Open Forum Infect Dis. 2020 Oct 22;7(12):ofaa512
pubmed: 33330740